Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2005
05/19/2005WO2004035565A8 Method for the synthesis of a benzimidazole compound
05/19/2005WO2003049678A3 Mitotic kinesin inhibitors
05/19/2005US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors
05/19/2005US20050107458 used as diagnostic kits, bioassay and/or drugs for preventing cancers, Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, epilepsy, multiple sclerosis, neuropathy, or injuries of the brain or spinal chord, or as tyrosine kinase inhibitors
05/19/2005US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto
05/19/2005US20050107443 Pyridoxine and pyridoxal analogues: new uses
05/19/2005US20050107429 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
05/19/2005US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders
05/19/2005US20050107423 Quinolone antibiotics such as 1-Cyclopropyl-6-fluoro-7-(4-hydroxy-hexahydro-cyclopenta[c]pyrrol-2-yl)-8-methyl-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid, used for treating gramnegative or grampositive bacterial infection in mammals
05/19/2005US20050107421 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
05/19/2005US20050107414 enzyme inhibitors such as N-(4-{4-[5-(2-Ethoxy-ethyl)-2,4,6-trioxo-hexahydro-pyrimidin-5-yloxy]-phenoxy}-benzyl)-acetamide, used for treating inflammation, cancers and other disorders
05/19/2005US20050107410 Compound possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
05/19/2005US20050107409 drugs such as 3-{[7-(2,5-dihydropyrrol-1-yl-carbonyl)-quinazolin-4-yl]aminomethyl}-4-hydroxy-benzamidine, used as anticoagulants
05/19/2005US20050107404 Mitotic kinesin inhibitors
05/19/2005US20050107403 Carbonylpyridine or carbonylpyrimindine compounds containing another nitrogen containing ring; useful in the treatment of inflammatory, metabolic or malignant conditions
05/19/2005US20050107401 2- (2-pyridyl) -5-phenyl-6-aminopyrimidine, method and intermediate products for the production and use thereof for combating noxious fungi
05/19/2005US20050107397 Sulfonamide derivatives as d3-receptor agonists
05/19/2005US20050107395 1-Methyl-cyclohexanecarboxylic acid {2-[4-(2-methoxy-phenyl)-piperazin-1-yl]-1-pyridin-3-ylmethyl-ethyl}-amide; used for treating a condition modulated by serotonin 5-HT1A receptors in the central nervous system and in the body of mammals
05/19/2005US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain
05/19/2005US20050107386 Methods of treating diseases and disorders by targeting multiple kinases
05/19/2005US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC
05/19/2005US20050107382 e.g. 2-(4-fluoro-2-methylphenyl)-5-(5-methoxymethyl-4-(6-methoxypyridin-3-yl)-4H-[1,2,4]triazol-3-yl)-pyridine; treatment of arousal disorder, orgasmic disorder, sexual pain disorder and premature ejaculation, preterm labor, appetite and feeding disorders, dysmenorrhoea, congestive heart failure, etc.
05/19/2005US20050107370 Pyrrole derivatives as antimycobacterial compounds
05/19/2005US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
05/19/2005US20050107362 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
05/19/2005US20050107355 Agonists of the kappa opioid receptor for treating gastrointestinal disorders, pain, and pruritus; N-{2-[(S)-3-hydroxy-pyrrolidin-1-yl]-(S)-1-phenyl-ethyl}-N-methyl-2-phenylamino-acetamide
05/19/2005US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease
05/19/2005US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
05/19/2005US20050107257 Derivatives of (1-benzyl-piperidine-4-yl)-diphenyl-methanol and their use as pesticide
05/19/2005US20050104042 Process for the synthesis of amine ethers from secondary amino oxides
05/19/2005CA2551056A1 Benzo[b][1,4]dioxepine derivatives
05/19/2005CA2544845A1 Preparation of pharmaceutical salts of [1, 4] - bipiperidine
05/19/2005CA2544748A1 Allosteric modulators of metabotropic glutamate receptors
05/19/2005CA2544678A1 Modulators of cellular adhesion
05/19/2005CA2543956A1 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/19/2005CA2543199A1 Use of crth2 antagonist compounds in therapy
05/19/2005CA2541212A1 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/19/2005CA2540704A1 Benzoimidazole compounds
05/18/2005EP1530569A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection
05/18/2005EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
05/18/2005EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway
05/18/2005EP1530566A1 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
05/18/2005EP1530564A2 Compounds derived from aryl carbamates, preparation thereof and uses of same
05/18/2005EP1530474A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors
05/18/2005EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
05/18/2005EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
05/18/2005EP1317430B1 (2-azabicyclo [2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
05/18/2005EP1263724B1 Novel compounds
05/18/2005EP1250047B9 Herbicidal composition
05/18/2005CN1617869A 4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
05/18/2005CN1617865A Phenylalkynes
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1)
05/18/2005CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617744A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
05/18/2005CN1617725A Tyrosyl derivatives and their use as P2X7 receptor modulators
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1616457A Crystals of benzimidazole derivatives and their production
05/18/2005CN1616456A Preparation of catifloxacin and purifying method
05/18/2005CN1616455A Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate
05/18/2005CN1616432A Compound, its use and pharmaceutical compositions comprising same
05/18/2005CN1616429A Red light emitting naphthyl imide compound and its synthetic method
05/18/2005CN1616425A Noval benzoindoline compounds, their preparing method and pharmaceutical composition containing them
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
05/18/2005CN1202085C Preparation of sterically hindered amine ethers
05/18/2005CN1202081C Amidino and guanidino bita-azetidinone tryptase inhibitors
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same
05/17/2005US6894165 Imidazonaphthyridines
05/17/2005US6894164 Process for the preparation of (pyridinylidene)-phthalides
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894068 Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase
05/17/2005US6894067 5-heteroatom-substituted pyrazoles
05/17/2005US6894066 Magnesium salt of S-omeprazole
05/17/2005US6894063 Drugs for treating metabolic and eating disorders, diabetes
05/17/2005US6894062 Modulation circadian rhythm disorders
05/17/2005US6894061 Substituted dihydrophenanthridinesulfonamides
05/17/2005US6894057 Administering to the living body a oxo-azabicyclo derivative to treat disease selected from arthritis, osteoporosis, periodontal diseases, inflammatory bowel disease, psoriasis, multiple sclerosis, asthma, cancer and macular degeneration
05/17/2005US6894052 Serotonergic receptor antagonist
05/17/2005US6894051 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
05/17/2005US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives
05/17/2005US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894044 Treatment of depression, anxiety, psychosis, obesity, pain, Parkinson's disease, Alzheimer's disease, neurodegenerative diseases, movement disorders, respiratory diseases, inflammatory diseases, neuropathy, immune disorders, etc.
05/17/2005US6893471 For dyeing human hair
05/17/2005US6892568 Noise detection system and method
05/17/2005CA2306782C Isoquinolines as urokinase inhibitors
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301548C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/17/2005CA2158057C Novel 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 1080